Assyro AI

Orange Book product · Generic (ANDA)

OXYBUTYNIN CHLORIDE

OXYBUTYNIN CHLORIDE

Generic (ANDA)ANDA 075039TE AARX CHARTWELL RX

At a glance

Jan 29, 1999

Approved

Generic (ANDA)

Application

AA

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 29, 1999

    27 yr 9 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

OXYBUTYNIN CHLORIDE

Strength

5MG/5ML

Dosage form

SYRUP

Route

ORAL

TE code

AA

Application

ANDA 075039

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of OXYBUTYNIN CHLORIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.